For example, if chronic p53 activity in DBA patient cells, which suppresses their proliferation, creates a growth advantage for p53-mutant cells and the accumulation of mutant cells within tissues then facilitates tumorigenesis, this would predict that the majority of DBA patient tumors should be p53 defective. Here, TP53 is linked to Diamond-Blackfan anemia.